会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Removable Wallboard System
    • 可移动墙板系统
    • US20090077922A1
    • 2009-03-26
    • US12237825
    • 2008-09-25
    • Thomas PettineHoward Jones
    • Thomas PettineHoward Jones
    • E04B1/38E04B1/00
    • E04B2/7457E04B2002/725E04B2002/7462E04F13/0814E04F19/02E04F19/022E04F19/061E04F19/062E04F19/064E04F19/067
    • The present invention is a novel removable wallboard system. It includes a plurality of receiver strips [1] which are attached to framing members [8] of a structure to be paneled. Each receiver strip has a receiving channel [4]. Wall panels 7 are placed snugly between the receiver strips [1]. Trim units [2] are elongated strips having insertion strips [10] which are designed to fit into and be retained by receiving channels [4] of the receiver strips [1]. Since the trim units [2] are designed to have a low profile, and they cover the seams between the wall panels [7], there is no need for further finishing or caulking. Therefore, these wall panels [7] may be removed and replaced with minimal effort or cleanup. The system also includes easily installable, removable and replaceable base molding [16], crown molding [19], and chair rail molding [29]. These may be designed to create chase ways [18, 74] allowing hidden routing of electrical, utility cables, pipes and hoses. Since the system may interactively be constructed and removed, it is useful in business settings in which offices are constantly adjusted.
    • 本发明是一种新颖的可移动墙板系统。 它包括多个接收器条[1],它们连接到待镶板结构的框架件[8]上。 每个接收器条具有接收通道[4]。 壁板7紧密地放置在接收器条[1]之间。 修剪单元[2]是具有插入条[10]的细长条,其被设计成适应接收器条[1]的接收通道[4]并被其保持。 由于装饰单元[2]被设计成具有低轮廓,并且它们覆盖在墙板[7]之间的接缝,因此不需要进一步的精加工或铆接。 因此,这些墙板[7]可以以最小的努力或清理被移除和更换。 该系统还包括易于安装,可拆卸和可更换的基础成型模具[16],表冠成型模具[19]和椅子轨道成型模具[29]。 这些设计可以创建追逐方式[18,74],允许电气,公用电缆,管道和软管的隐藏路由。 由于系统可以交互式地构建和删除,因此在不断调整办公室的业务环境中是有用的。
    • 3. 发明申请
    • SYSTEM FOR GENERATING INSPECTION REPORTS FOR INSPECTED ITEMS
    • 检查检验报告系统
    • US20060259392A1
    • 2006-11-16
    • US10908535
    • 2005-05-16
    • Nancy RabenoldJames SimmonsPeter OgdenHoward JonesLewis Glow
    • Nancy RabenoldJames SimmonsPeter OgdenHoward JonesLewis Glow
    • G06Q40/00
    • G06Q30/0609G06F17/30371G06Q10/10G06Q40/04
    • An electronic inspection report system includes a central report generator and a data collection device. The central report generator is adapted to produce multiple types of inspection report template. The central report generator is adapted to select a type of inspection report template to provide to a data collection device based upon various criteria. The central report generator is adapted to receive electronic information from various databases and format the information such that the information can be used in inspection reports. While inspecting an item, an inspector uses a data collection device to access an inspection report template and fill in fields of the inspection report template. The data collection device can be configured to check the consistency of information carried in fields of the inspection report and signal the inspector when some of the information is inconsistent. The central report generator can include a repository of completed inspection reports. The central report generator can be configured to mine the repository of completed inspection reports and determine correlations between fields of the completed inspection reports. Software in the data collection device can updated such that the data collection device can perform consistency checks between fields that the central report generator has determined have a correlation.
    • 电子检查报告系统包括中央报告发生器和数据收集装置。 中央报告生成器适用于生成多种类型的检查报告模板。 中央报告生成器适于根据各种标准选择一种检查报告模板以提供给数据收集装置。 中央报告生成器适用于从各种数据库接收电子信息,并格式化信息,以便信息可以在检验报告中使用。 在检查项目时,检查员使用数据收集设备访问检查报告模板并填写检查报告模板的字段。 数据采集​​装置可以被配置为检查在检查报告的领域中携带的信息的一致性,并且当某些信息不一致时发出信号。 中央报告生成器可以包括已完成的检查报告的存储库。 中央报告生成器可以配置为挖掘完成的检查报告的存储库,并确定完成的检查报告的字段之间的相关性。 可以更新数据收集装置中的软件,使得数据收集装置可以执行中央报告生成器确定的相关的字段之间的一致性检查。
    • 5. 发明授权
    • Antihypertensive amide compounds
    • 抗高血压酰胺化合物
    • US4839367A
    • 1989-06-13
    • US895107
    • 1986-08-11
    • Raymond D. YoussefyehHoward Jones
    • Raymond D. YoussefyehHoward Jones
    • A61K31/47C07D209/02C07D209/36C07D211/72
    • A61K31/47C07D209/02C07D209/36C07D211/72
    • Provided are antihypertensive compounds of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, and R.sub.6 are hydrogen, alkyl, alkenyl, alkynyl, phenyl-alkyl, or cycloalkyl, and may be the same or different,m is an integer from 0 to 2 inclusive,n is an integer from 0 to 4 inclusive,M is alkyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, polycycloalkyl, polycycloalkyl-alkyl, aryl, aralkyl, heteroaryl, heteroaryl-alkyl, hetero-cycloalkyl, hetero-cycloalkyl-alkyl, fused aryl-cycloalkyl, fused aryl-cycloalkyl-alkyl, fused heteroaryl-cycloalkyl, fused heteroaryl-cycloalkyl-alkyl, alkoxyalkyl, alkylthioalkyl, alkylamino-alkyl, or dialkylaminoalkyl,Y is hydroxy, alkoxy, amino, or substituted amino, aminoalkanoyl, aryloxy, aminoalkoxy, or hydroxyalkoxy, andR.sub.7 is alkyl, aryl, aralkyl, cycloalkyl, cycloalkyl-alkyl, heterocyclic, --CO--SR, --CS--SR, ##STR2## CH.sub.2 CO.sub.R, --CHM--CO.sub.2 R, --CH.sub.2 --CO--SR, --CN, ##STR3## --CO--NH--CH.sub.2 CO.sub.2 R, ##STR4## or --CO--CO.sub.2 CO.sub.2 R, wherein R is hydrogen, alkyl, or aryl, and where Y is hydroxy, their pharmaceutically acceptable, nontoxic alkali metal, alkaline earth metal, and amine salts.
    • 本发明提供了下式的抗高血压化合物:其中R1,R2,R3,R4,R5和R6是氢,烷基,烯基,炔基,苯基 - 烷基或环烷基,并且可以相同或不同,m是 0〜2的整数,n为0〜4的整数,M为烷基,炔基,环烷基,环烷基 - 烷基,多环烷基,多环烷基 - 烷基,芳基,芳烷基,杂芳基,杂芳基 - 烷基,杂环烷基, 稠合芳基 - 环烷基,稠合芳基 - 环烷基 - 烷基,稠合的杂芳基 - 环烷基,稠合的杂芳基 - 环烷基 - 烷基,烷氧基烷基,烷硫基烷基,烷基氨基 - 烷基或二烷基氨基烷基,Y是羟基,烷氧基,氨基或取代 氨基,氨基烷酰基,芳氧基,氨基烷氧基或羟基烷氧基,R7是烷基,芳基,芳烷基,环烷基,环烷基 - 烷基,杂环基,-CO-SR,-CS-SR,CH2COR,-CHM-CO2R,-CH2 -CO-SR,-CN, -CO-NH-CH 2 CO 2 R,IMA或-CO-CO 2 CO 2 R,其中R是氢,烷基或芳基,并且其中Y是羟基, 药学上可接受的,无毒的碱金属,碱土金属和胺盐。
    • 9. 发明授权
    • Aroylaminoacid disulfides
    • 芳酰胺酸二硫化物
    • US4479950A
    • 1984-10-30
    • US439525
    • 1982-11-05
    • Paul R. MenardHoward JonesJohn T. Suh
    • Paul R. MenardHoward JonesJohn T. Suh
    • A61K31/195A61K31/215C07D307/58C07D401/12C07D407/12C07D409/12C07D413/12C07C149/40C07C149/41
    • C07C323/00C07C327/00
    • Compounds of the structure ##STR1## wherein: P and Q are independently hydrogen, halo, CF.sub.3, OR.sub.1, SR.sub.1, sulfamoyl, alkyl and NR.sub.1 R.sub.2 ;R.sub.1, and R.sub.2 are independently hydrogen, alkyl, aminoalky, aryl, aralkyl, heteroaryl or cycloalkyl;Y is OH, OR.sub.1, NH.sub.2, or, N(R.sub.1 R.sub.2); andM is alkyl, cycloalkyl, aryl, aminoalkyl, aralkyl, heteroaryl or heterocyclicwherein:the alkyl groups and the alkyl moieties of aminoalkyl, alkoxy and thioalkyl contain from 1 to 6 carbon atoms; the cycloalkyl group contains from 3 to 8 carbon atoms; the aryl group contains from 6 to 10 carbon atoms; the aralkyl group contains from 7 to 16 carbon atoms; and the hetero group is selected from pyrrolidyl, piperidinyl, morpholinyl, pyridyl, quinolinyl, furyl, furfuryl and thienyl; and where Y is a hydroxy, their pharmaceutically acceptable, non-toxic alkali, alkaline earth and amine salts, have angiotensin converting enzyme inhibitory activity.
    • 其中:P和Q独立地是氢,卤素,CF 3,OR 1,SR 1,氨磺酰基,烷基和NR 1 R 2; R1和R2独立地是氢,烷基,氨基烷基,芳基,芳烷基,杂芳基或环烷基; Y是OH,OR1,NH2或N(R1R2); 并且M是烷基,环烷基,芳基,氨基烷基,芳烷基,杂芳基或杂环,其中:烷基和氨基烷基,烷氧基和硫代烷基的烷基部分含有1至6个碳原子; 环烷基含有3至8个碳原子; 芳基含有6至10个碳原子; 芳烷基含有7至16个碳原子; 杂基选自吡咯烷基,哌啶基,吗啉基,吡啶基,喹啉基,呋喃基,糠基和噻吩基; 并且其中Y是羟基,其药学上可接受的,无毒的碱金属,碱土金属和胺盐具有血管紧张素转化酶抑制活性。